At the opening of the recent 25th Harm Reduction International Conference in Montreal, the Minister of Health Jane Philpott announced that more people have died in the overdose epidemic in the past few years than died during the height of the AIDS crisis in the late 80s and early 90s. In 2016, it is estimated that 2,300 people died of overdose—preventable deaths caused by the prohibition of drugs.
In response to that sobering and sad announcement, we wrote an article asking for people engaged in the response to HIV to show support and solidarity with people who use drugs. We believe that making connections between the two epidemics can help build solidarity, increase public support and mobilize people into action to address the national overdose crisis. We wrote:
“People who have lived through the AIDS crisis, who work in HIV organizations, who call themselves allies of the HIV community, who have attended an HIV fundraiser, who have learned about the history of AIDS activism, we make an appeal to you: The time for you to step up and end the massive injustice taking place against people who use drugs is now. We need more resources. We need the government to take our solutions seriously. We need the overdose epidemic to be declared a national emergency. Help us do this.”
So what can you do if you want to show support and solidarity? Here are six things you and your organization can do:
The Canadian Task Force on Preventative Health Care (CTFPHC) released its HCV Screening Guidelines today in the Canadian Medical Association Journal on Monday. To the dismay of experts across Canada including hepatitis C specialists, advocacy groups, and stakeholders, the new screening guidelines ignore expert advice regarding who should be tested for Hep C, setting a dangerous public health policy where dollars come first and the health of Canadians comes last.
Early this year, British Columbia, Alberta, Saskatchewan, Quebec and Ontario announced the lowering of eligibility requirements for access to public coverage for life-changing hepatitis C drugs, including Epclusa, Zepatier, daclatasvir and asunaprevir. These drugs will be available to those with lower fibrosis scores for the first time (the greater the fibrosis score, the more severe the liver scarring, or cirrhosis, caused by disease.)[i]
The emergence of PrEP has highlighted important gender inequalities in HIV transmission and HIV prevention. PrEP, or pre-exposure prophylaxis, is a drug that HIV-negative people (including women!) can take to help prevent HIV; however, most discussions about PrEP focus on men. Despite representing fewer new HIV infections than men, women also need innovative HIV prevention methods.
Je me vois souvent contraint de commencer mes billets sur le travail du sexe en parlant du Grand Prix de F1 de Montréal.
Chaque année, dans la foulée du Grand Prix – et particulièrement l’année dernière, en juin – les médias se font un plaisir, sinon un devoir, de prendre d’assaut ce qu’ils perçoivent comme une violente augmentation de l’exploitation sexuelle et de la traite des femmes dans le cadre de ces évènements sportifs. Cette médiatisation s’inscrit dans une approche abolitionniste aux effets néfastes, ceux-ci incluant une surveillance accrue, des arrestations plus fréquentes et des risques de déportation plus élevés pour les travailleuse(-eur)s du sexe.
The CATIE Blog hosts the views and opinions of people and organizations working and volunteering in Canada’s response to HIV and hepatitis C.